JUN 01, 2020 11:00 AM PDT

Procalcitonin in Emergency Department Patients With Suspected COVID-19

Sponsored by: bioMérieux Inc
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Walter H. and Leonore Annenberg Dean of the College of Medicine and Senior Vice President for Medical Affairs at Drexel University
    Biography
      Charles B. Cairns, M.D. is the Walter H. and Leonore Annenberg Dean of the College of Medicine and Senior Vice President for Medical Affairs at Drexel University where he serves as Professor of Medicine and Emergency Medicine. Previously, he served as Dean of the College of Medicine at the University of Arizona, as Chair of the Department of Emergency Medicine at the University of North Carolina and as Director of Emergency Medicine Research at the Duke Clinical Research Institute, the world's largest academic clinical research organization.

      Dr. Cairns' research interests include the host response of patients and populations to acute bacterial and viral infections, cardiopulmonary and trauma resuscitation. Dr. Cairns has served as Director of the NIH United States Critical Illness and Injury Trials Group and as Principal Investigator of the National Collaborative for Biopreparedness. He has published over 200 scientific articles and reviews and secured more than $30 million in research funding. Dr. Cairns has received numerous honors and awards, including the ACEP Outstanding Contribution in Research Award, EMF Established Investigator Award, National Foundation of Emergency Medicine Mentor Scholar Award, SCCM Presidential Citation Award and the SAEM John Marx Leadership Award, the highest award in academic emergency medicine. Dr. Cairns is an honors graduate of Dartmouth College and received his medical degree from the University of North Carolina, where he was a Holderness Medical Fellow and received the Medical Faculty Award as the outstanding graduating medical student. He is a fellow of the American College of Emergency Physicians, the American Academy of Emergency Medicine and the American Heart Association

    Abstract

    DATE:  June 1, 2020

    TIME:   11:00am PDT, 2:00pm EDT

     

    This webinar will provide an overview of the host response to bacterial and viral infections. The rationale for the use of procalcitonin in assessing the host response will be discussed, including distinguishing bacterial from nonbacterial infections. Finally, an overview will be provided on the role of procalcitonin in assessing the host response in emergency department patients with suspected COVID-19. 

     

    Learning Objectives:

    • Describe and understand the host response to bacterial and viral infections.
    • Describe and understand the rationale for the assessment of procalcitonin in patients with suspected infections.
    • Describe and understand approaches to assessing the host response to infection patients with suspected COVID-19 in the emergency department, including the role of procalcitonin. 

     

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more